Afrah Fatthi Salama

6PUBLICATIONS
2CO-AUTHORS
Molecular targetsTraditional Chinese medicine and treatmentsPredictive and prognostic markersBioremediation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 22, 2024
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression.

Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar

|Jan 16, 2024
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression.

Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar

|Sep 19, 2023
Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death.

Tarek El-Sewedy, Afrah Fatthi Salama, Amro E Mohamed

|May 09, 2023
Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer.

Alaa Elmetwalli, Shimaa Mustafa Hashish, Mervat G Hassan

|May 05, 2023
Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action.

Alaa Elmetwalli, Thoria Diab, Aisha Nawaf Albalawi

|Apr 29, 2023
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents.

Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan

Pageof 1